SynthesisJournal of gastrointestinal cancer2025

Do Incretin-Based Therapies Influence the Risk of Cholangiocarcinoma in Type 2 Diabetes Patients? Insights from a Systematic Review and Meta-Analysis.

Eric Ricardo Yonatan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.